Información del producto
CXD101 is a small molecule inhibitor of histone deacetylase (HDAC) enzymes. It is a potent, selective, and reversible inhibitor of HDACs 1, 2, and 3. CXD101 has been shown to induce cell death in solid tumours through the inhibition of HDACs. In vitro studies have shown that it inhibits the growth of cancer cells by inducing apoptosis and inhibiting the transcriptional activity of Hdac enzymes on histones. These findings indicate that CXD101 may be useful for the treatment of cancers. CXD101 has been well tolerated in clinical trials with no significant adverse effects reported.
CXD101 is an amide-linked prodrug which undergoes rapid acetylation by esterases in vivo to form its active metabolite, cixutumumab (CX1001). Acetylation occurs mainly in the liver, followed by rapid elimination from plasma with a half-life of
Propiedades químicas
Consulta técnica sobre: 3D-JMB82812 CXD101
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
